Pluvicto (lutetium Lu 177 vipivotide tetraxetan) has been approved for the treatment of adult patients with prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer who have received androgen receptor pathway inhibition and taxane-based chemotherapy.
yar
劲秉
坚强的广山
藤椒辣鱼
cocolu
竹筏过海
把心放在肚里
aldehyde
iNk
厉不厉害你坤哥
HEIKU
暴躁的老哥
毛豆
小黑喵
飞天三叉戟
Excalibur
Mrivy
ceeray23
SYLH
pluto
皖公网安备34019202002308
